Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
NEVRO CORP
| Metric | NEVRO CORP NVROHealthcare |
|---|---|
| Quality Score | 42 / 100 |
| Revenue (latest) | $409M |
| Net income (latest) | −$113M |
| Operating margin | −30.9% |
| Net margin | −27.8% |
| Return on equity | −49.1% |
| Return on assets | −20.5% |
| Return on capital (ROCE) | −28.0% |
| Debt / equity | 1.40× |
| Revenue growth (YoY) | −3.9% |
| Altman Z″ (distress) | -1.15 |
| Accruals / assets | −17.0% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.